NCT02127476 A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02119546 Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease Status COMPLETED Phase NA
NCT02114372 Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study Status COMPLETED Phase N/A
NCT02097056 Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT02094729 A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02089555 African American Alzheimer's Progression Markers - CSF and Neuro-Imaging Status COMPLETED Phase N/A
NCT02085265 Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients Status TERMINATED Phase PHASE2
NCT02080364 Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02079909 Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202) Status COMPLETED Phase PHASE2
NCT02079246 Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT02078310 Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia Status COMPLETED Phase PHASE1/PHASE2
NCT02074215 Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease Status COMPLETED Phase NA
NCT02064920 Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) Status COMPLETED Phase PHASE2
NCT02063269 Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles Status UNKNOWN Phase NA
NCT02061878 A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02054208 Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE1/PHASE2